Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns
Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns
Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns
Submitted by
admin
on February 6, 2017 - 11:13am
Source:
Marketwatch
News Tags:
Galena Biopharma
breast cancer
NeuVax
clinical trials
Headline:
Galena Biopharma stock surges 21% after independent group says breast cancer drug has no safety concerns
Do Not Allow Advertisers to Use My Personal information
